Please wait a minute...
 Home  About the Journal Editorial Board Aims & Scope Peer Review Policy Subscription Contact us
 
Early Edition  //  Current Issue  //  Open Special Issues  //  Archives  //  Most Read  //  Most Downloaded  //  Most Cited
Aging and Disease    2018, Vol. 9 Issue (2) : 192-207     DOI: 10.14336/AD.2017.0429
Orginal Article |
The Prevalence of Frailty and its Associated Factors in Japanese Hemodialysis Patients
Hidemi Takeuchi1,7,Haruhito A. Uchida1,2,*,Yuki Kakio1,Yuka Okuyama1,Michihiro Okuyama3,Ryoko Umebayashi1,Kentaro Wada4,Hitoshi Sugiyama1,5,Ken Sugimoto6,Hiromi Rakugi6,Jun Wada1
1Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
2Department of Chronic Kidney Disease and Cardiovascular Disease, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
3Department of Cardiovascular Surgery, Okayama University Hospital, Okayama, Japan.
4Division of Nephrology and Dialysis, Department of Internal Medicine, Nippon Kokan Fukuyama Hospital, Hiroshima, Japan.
5Department of Human Resource Development of Dialysis Therapy for Kidney Disease, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
6Department of Geriatric and General Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
7Department of Internal Medicine, Innoshima General Hospital, Hiroshima, Japan
Download: PDF(1251 KB)   HTML
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks    
Abstract  

The population undergoing dialysis is aging worldwide, particularly in Japan. The clinical condition of frailty is the most problematic expression in the elderly population. Potential pathophysiological factors of frailty present in patients with CKD and are accentuated in patients with ESRD. The aim of this study was to identify the prevalence and predictors of frailty in Japanese HD patients. This study was a multicenter, cross-sectional and observational investigation conducted at 6 institutions. To evaluate frailty, the modified Fried’s frailty phenotype adjusted for Japanese as the self-reported questionnaire was used. Of the 542 patients visiting each institution, 388 were enrolled in this study. In total, 26.0% of participants were categorized as not-frailty, 52.6% as pre-frailty and 21.4% as frailty. The prevalence of frailty increased steadily with age and was more prevalent in females than in males and the subjects with frailty received polypharmacy. A multivariate logistic regression analysis revealed that the factors independently associated with frailty were the following: female gender (odds ratio [OR] = 3.661, 95% confidence interval [CI] 1.398-9.588), age (OR = 1.065, 95% CI 1.014-1.119), age ≥ 75 years old (OR = 4.892, 95% CI 1.715-13.955), body mass index (BMI) < 18.5 (OR = 0.110, 95% CI 0.0293-0.416), number of medications being taken (OR = 1.351, 95% CI 1.163-1.570), diabetes mellitus (DM) (OR = 2.765, 95% CI 1.081-7.071) and MNA-SF ≤ 11 (OR = 7.405, 95% CI 2.732-20.072). Frailty was associated with the accumulation of risk factors. The prevalence of frailty in Japanese patients with HD was relatively lower than that previously reported in Western developed countries; however, it was extremely high compared to the general population regardless of age. Our findings suggest that frailty might be associated with an increase in the prevalence of adverse health outcomes in patients with HD.

Keywords Frailty      Dialysis      Frailty phenotype     
Corresponding Authors: Haruhito A. Uchida   
Issue Date: 01 April 2018
Service
E-mail this article
E-mail Alert
RSS
Articles by authors
Hidemi Takeuchi
Haruhito A. Uchida
Yuki Kakio
Yuka Okuyama
Michihiro Okuyama
Ryoko Umebayashi
Kentaro Wada
Hitoshi Sugiyama
Ken Sugimoto
Hiromi Rakugi
Jun Wada
Cite this article:   
Hidemi Takeuchi,Haruhito A. Uchida,Yuki Kakio, et al. The Prevalence of Frailty and its Associated Factors in Japanese Hemodialysis Patients[J]. A&D, 2018, 9(2): 192-207.
URL:  
http://www.aginganddisease.org/EN/10.14336/AD.2017.0429     OR     http://www.aginganddisease.org/EN/Y2018/V9/I2/192
[1] GBD2015 Mortality and Causes of Death Collaborators (2016). Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet, 388: 1459-1544
[2] GBD2015 DALYs and HALE Collaborators (2016). Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet, 388: 1603-1658
[3] Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K (2013). Frailty in elderly people. Lancet, 381: 752-762
[4] Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. (2001). Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci, 56: M146-156
[5] Woods NF, LaCroix AZ, Gray SL, Aragaki A, Cochrane BB, Brunner RL, et al. (2005). Frailty: emergence and consequences in women aged 65 and older in the Women’s Health Initiative Observational Study. J Am Geriatr Soc, 53: 1321-1330
[6] Bartali B, Frongillo EA, Bandinelli S, Lauretani F, Semba RD, Fried LP, et al. (2006). Low nutrient intake is an essential component of frailty in older persons. J Gerontol A Biol Sci Med Sci, 61: 589-593
[7] Buchman AS, Boyle PA, Wilson RS, Tang Y, Bennett DA (2007). Frailty is associated with incident Alzheimer’s disease and cognitive decline in the elderly. Psychosom Med, 69: 483-489
[8] Handforth C, Clegg A, Young C, Simpkins S, Seymour MT, Selby PJ, et al. (2015). The prevalence and outcomes of frailty in older cancer patients: a systematic review. Ann Oncol, 26: 1091-1101
[9] Musso CG, Jauregui JR, Macias Nunez JF (2015). Frailty phenotype and chronic kidney disease: a review of the literature. Int Urol Nephrol, 47: 1801-1807
[10] Masakane I, Nakai S, Ogata S, Kimata N, Hanafusa N, Hamano T, et al. (2015). An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013). Ther Apher Dial, 19: 540-574
[11] Kim JC, Kalantar-Zadeh K, Kopple JD (2013). Frailty and protein-energy wasting in elderly patients with end stage kidney disease. J Am Soc Nephrol, 24: 337-351
[12] Yamada M, Arai H, Nishiguchi S, Kajiwara Y, Yoshimura K, Sonoda T, et al. (2013). Chronic kidney disease (CKD) is an independent risk factor for long-term care insurance (LTCI) need certification among older Japanese adults: a two-year prospective cohort study. Arch Gerontol Geriatr, 57: 328-332
[13] Chen S, Honda T, Chen T, Narazaki K, Haeuchi Y, Supartini A, et al. (2015). Screening for frailty phenotype with objectively-measured physical activity in a west Japanese suburban community: evidence from the Sasaguri Genkimon Study. BMC Geriatr, 15: 36
[14] Makizako H, Shimada H, Doi T, Tsutsumimoto K, Suzuki T (2015). Impact of physical frailty on disability in community-dwelling older adults: a prospective cohort study. BMJ Open, 5: e008462
[15] Shinzato T, Nakai S, Fujita Y, Takai I, Morita H, Nakane K, et al. (1994). Determination of Kt/V and protein catabolic rate using pre- and postdialysis blood urea nitrogen concentrations. Nephron, 67: 280-290
[16] Depner TA, Daugirdas JT (1996). Equations for normalized protein catabolic rate based on two-point modeling of hemodialysis urea kinetics. J Am Soc Nephrol, 7: 780-785
[17] Kobayashi I, Ishimura E, Kato Y, Okuno S, Yamamoto T, Yamakawa T, et al. (2010). Geriatric Nutritional Risk Index, a simplified nutritional screening index, is a significant predictor of mortality in chronic dialysis patients. Nephrol Dial Transplant, 25: 3361-3365
[18] Lilamand M, Kelaiditi E, Cesari M, Raynaud-Simon A, Ghisolfi A, Guyonnet S, et al. (2015). Validation of the Mini Nutritional Assessment-Short Form in a Population of Frail Elders without Disability. Analysis of the Toulouse Frailty Platform Population in 2013. J Nutr Health Aging, 19: 570-574
[19] Fukutomi E, Okumiya K, Wada T, Sakamoto R, Ishimoto Y, Kimura Y, et al. (2013). Importance of cognitive assessment as part of the "Kihon Checklist" developed by the Japanese Ministry of Health, Labor and Welfare for prediction of frailty at a 2-year follow up. Geriatr Gerontol Int, 13: 654-662
[20] Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS, et al. (2014). Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc, 15: 95-101
[21] Johansen KL, Chertow GM, Jin C, Kutner NG (2007). Significance of frailty among dialysis patients. J Am Soc Nephrol, 18: 2960-2967
[22] Bao Y, Dalrymple L, Chertow GM, Kaysen GA, Johansen KL (2012). Frailty, dialysis initiation, and mortality in end-stage renal disease. Arch Intern Med, 172: 1071-1077
[23] Johansen KL, Delgado C, Bao Y, Kurella Tamura M (2013). Frailty and dialysis initiation. Semin Dial, 26: 690-696
[24] McAdams-DeMarco MA, Law A, Salter ML, Boyarsky B, Gimenez L, Jaar BG, et al. (2013). Frailty as a novel predictor of mortality and hospitalization in individuals of all ages undergoing hemodialysis. J Am Geriatr Soc, 61: 896-901
[25] Johansen KL, Dalrymple LS, Glidden D, Delgado C, Kaysen GA, Grimes B, et al. (2016). Association of Performance-Based and Self-Reported Function-Based Definitions of Frailty with Mortality among Patients Receiving Hemodialysis. Clin J Am Soc Nephrol, 11: 626-632
[26] Johansen KL (2015). The Frail Dialysis Population: A Growing Burden for the Dialysis Community. Blood Purif, 40: 288-292
[27] Morley JE, Vellas B, van Kan GA, Anker SD, Bauer JM, Bernabei R, et al. (2013). Frailty consensus: a call to action. J Am Med Dir Assoc, 14: 392-397
[28] Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, et al. (2008). A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int, 73: 391-398
[29] Foley RN, Wang C, Ishani A, Collins AJ, Murray AM (2007). Kidney function and sarcopenia in the United States general population: NHANES III. Am J Nephrol, 27: 279-286
[30] Koopman JJ, Rozing MP, Kramer A, de Jager DJ, Ansell D, De Meester JM, et al. (2011). Senescence rates in patients with end-stage renal disease: a critical appraisal of the Gompertz model. Aging Cell, 10: 233-238
[31] Kooman JP, Broers NJ, Usvyat L, Thijssen S, van der Sande FM, Cornelis T, et al. (2013). Out of control: accelerated aging in uremia. Nephrol Dial Transplant, 28: 48-54
[32] Wilhelm-Leen ER, Hall YN, M KT, Chertow GM (2009). Frailty and chronic kidney disease: the Third National Health and Nutrition Evaluation Survey. Am J Med, 122: 664-671.e662
[33] Collard RM, Boter H, Schoevers RA, Oude Voshaar RC (2012). Prevalence of frailty in community-dwelling older persons: a systematic review. J Am Geriatr Soc, 60: 1487-1492
[34] Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, et al. (2003). Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol, 14: 3270-3277
[35] Perl J, Karaboyas A, Morgenstern H, Sen A, Rayner HC, Vanholder RC, et al. (2016). Association between changes in quality of life and mortality in hemodialysis patients: results from the DOPPS. Nephrol Dial Transplant
[36] Chang YW, Chen WL, Lin FG, Fang WH, Yen MY, Hsieh CC, et al. (2012). Frailty and its impact on health-related quality of life: a cross-sectional study on elder community-dwelling preventive health service users. PLoS One, 7: e38079
[37] Shinaberger CS, Kilpatrick RD, Regidor DL, McAllister CJ, Greenland S, Kopple JD, et al. (2006). Longitudinal associations between dietary protein intake and survival in hemodialysis patients. Am J Kidney Dis, 48: 37-49
[38] Segall L, Mardare NG, Ungureanu S, Busuioc M, Nistor I, Enache R, et al. (2009). Nutritional status evaluation and survival in haemodialysis patients in one centre from Romania. Nephrol Dial Transplant, 24: 2536-2540
[39] Dent E, Visvanathan R, Piantadosi C, Chapman I (2012). Use of the Mini Nutritional Assessment to detect frailty in hospitalised older people. J Nutr Health Aging, 16: 764-767
[40] Bollwein J, Volkert D, Diekmann R, Kaiser MJ, Uter W, Vidal K, et al. (2013). Nutritional status according to the mini nutritional assessment (MNA(R)) and frailty in community dwelling older persons: a close relationship. J Nutr Health Aging, 17: 351-356
[41] Dorner TE, Luger E, Tschinderle J, Stein KV, Haider S, Kapan A, et al. (2014). Association between nutritional status (MNA(R)-SF) and frailty (SHARE-FI) in acute hospitalised elderly patients. J Nutr Health Aging, 18: 264-269
[1] Faheemuddin Azher Ahmed. Kidney Disease in Elderly: Importance of Collaboration between Geriatrics and Nephrology[J]. A&D, 2018, 9(4): 745-747.
[2] Emma EF. Kleipool,Emiel O. Hoogendijk,Marijke C. Trappenburg,M. Louis Handoko,Martijn Huisman,Mike JL. Peters,Majon Muller. Frailty in Older Adults with Cardiovascular Disease: Cause, Effect or Both?[J]. A&D, 2018, 9(3): 489-497.
[3] Ilia Stambler. Recognizing Degenerative Aging as a Treatable Medical Condition: Methodology and Policy[J]. A&D, 2017, 8(5): 583-589.
[4] Lucia Tortorella,Giuseppe Vizzielli,Domenico Fusco,William C. Cho,Roberto Bernabei,Giovanni Scambia,Giuseppe Colloca. Ovarian Cancer Management in the Oldest Old: Improving Outcomes and Tailoring Treatments[J]. A&D, 2017, 8(5): 677-684.
[5] Hongxia Zhang,Fen Sun,Jixian Wang,Luokun Xie,Chenqi Yang,Mengxiong Pan,Bei Shao,Guo-Yuan Yang,Shao-Hua Yang,Qichuan ZhuGe,Kunlin Jin. Combining Injectable Plasma Scaffold with Mesenchymal Stem/Stromal Cells for Repairing Infarct Cavity after Ischemic Stroke[J]. A&D, 2017, 8(2): 203-214.
[6] Iranzu Mugueta-Aguinaga, Begonya Garcia-Zapirain. Is Technology Present in Frailty? Technology a Back-up Tool for Dealing with Frailty in the Elderly: A Systematic Review[J]. A&D, 2017, 8(2): 176-195.
[7] Ahmed H Abdelhafiz,Alan J Sinclair. Low HbA1c and Increased Mortality Risk-is Frailty a Confounding Factor?[J]. A&D, 2015, 6(4): 262-270.
[8] Ahmed H Abdelhafiz,Leocadio Rodríguez-Mañas,John E. Morley,Alan J Sinclair. Hypoglycemia in Older People - A Less Well Recognized Risk Factor for Frailty[J]. A&D, 2015, 6(2): 156-167.
[9] Alexandra Moura,José Madureira,Pablo Alija,João Carlos Fernandes,José Gerardo Oliveira,Martin Lopez,Madalena Filgueiras,Leonilde Amado,Maria Sameiro-Faria,Vasco Miranda,Alice Santos-Silva,Elísio Costa. Effect of Aging in the Perception of Health-Related Quality of Life in End-Stage Renal Disease Patients under Online-Hemodiafiltration[J]. Aging and Disease, 2015, 6(1): 17-26.
[10] Eduardo Lusa Cadore,Ronei Silveira Pinto,Martim Bottaro,Mikel Izquierdo. Strength and Endurance Training Prescription in Healthy and Frail Elderly[J]. Aging and Disease, 2014, 5(3): 183-195.
[11] Ahmed H Abdelhafiz,Boon Eng Loo,Nicola Hensey,Claire Bailey,Alan Sinclair. The U-shaped Relationship of Traditional Cardiovascular Risk Factors and Adverse Outcomes in Later Life[J]. Aging and Disease, 2012, 3(6): 454-464.
[12] Periklis Dousdampanis,Konstantina Trigka,Costas Fourtounas. Diagnosis and Management of Chronic Kidney Disease in the Elderly: a Field of Ongoing Debate[J]. Aging and Disease, 2012, 3(5): 360-372.
[13] Kristin A. Lowry,Abbe N. Vallejo,Stephanie A. Studenski. Successful Aging as a Continuum of Functional Independence: Lessons from Physical Disability Models of Aging[J]. Aging and Disease, 2012, 3(1): 5-15.
[14] Huifen Li,Bhavish Manwani,Sean X. Leng. Frailty, Inflammation, and Immunity[J]. Aging and Disease, 2011, 2(6): 466-473.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
Copyright © 2014 Aging and Disease, All Rights Reserved.
Address: Aging and Disease Editorial Office 3400 Camp Bowie Boulevard Fort Worth, TX76106 USA
Fax: (817) 735-0408 E-mail: editorial@aginganddisease.org
Powered by Beijing Magtech Co. Ltd